{
    "title": "Akebia plunges 73% after anemia treatment fails to meet safety goal",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8694093/Akebia-Therapeutics-anemia-treatment-fails-meet-safety-goal-late-stage-study.html",
    "date": "2020-09-03",
    "keywords": [
        "drug",
        "safety",
        "goal",
        "treatment",
        "kidney",
        "disease",
        "study",
        "latestage",
        "trial",
        "dialysis",
        "company",
        "akebia",
        "nondialysis",
        "analyst",
        "efficacy",
        "thursday",
        "companys",
        "record",
        "low",
        "concern",
        "blow",
        "boost",
        "inc",
        "fibrogen",
        "market",
        "michael",
        "food",
        "administration",
        "dec",
        "marketing",
        "application",
        "fda",
        "dependent",
        "vadadustat",
        "versus",
        "amgen",
        "darbepoetin",
        "noninferiority",
        "alfa",
        "time",
        "occurrence",
        "cardiovascular",
        "uncertainty",
        "dialysisdependent",
        "capital",
        "mackay",
        "anemia",
        "condition",
        "person",
        "blood",
        "oxygen",
        "bodys",
        "society",
        "hematology",
        "reporting",
        "dania",
        "nadeem",
        "bengaluru",
        "editing",
        "shounak",
        "dasgupta"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}